Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells - Nature Medicine
- ️Lapidot, Tsvee
- ️Sun May 21 2006
Teitelbaum, S.L. Bone resorption by osteoclasts. Science 289, 1504–1508 (2000).
Boyle, W.J., Simonet, W.S. & Lacey, D.L. Osteoclast differentiation and activation. Nature 423, 337–342 (2003).
Adams, G.B. & Scadden, D.T. The hematopoietic stem cell in its place. Nat. Immunol. 7, 333–337 (2006).
Ponomaryov, T. et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J. Clin. Invest. 106, 1331–1339 (2000).
Cottler-Fox, M.H. et al. Stem cell mobilization. Hematology (Am. Soc. Hematol. Educ. Program) 419–437 (2003).
Lapidot, T., Dar, A. & Kollet, O. How do stem cells find their way home? Blood 106, 1901–1910 (2005).
Heissig, B. et al. Recruitment of stem and progenitor cells from the bone marrow niche requires mmp-9 mediated release of kit-ligand. Cell 109, 625–637 (2002).
Petit, I. et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3, 687–694 (2002).
Levesque, J.P., Hendy, J., Takamatsu, Y., Simmons, P.J. & Bendall, L.J. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J. Clin. Invest. 111, 187–196 (2003).
Takamatsu, Y. et al. Osteoclast-mediated bone resorption is stimulated during short-term administration of granulocyte colony-stimulating factor but is not responsible for hematopoietic progenitor cell mobilization. Blood 92, 3465–3473 (1998).
Watanabe, T. et al. Effect of granulocyte colony-stimulating factor on bone metabolism during peripheral blood stem cell mobilization. Int. J. Hematol. 77, 75–81 (2003).
Rothe, L. et al. Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8. Endocrinology 139, 4353–4363 (1998).
Pruijt, J.F. et al. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). Proc. Natl. Acad. Sci. USA 96, 10863–10868 (1999).
Kollet, O. et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J. Clin. Invest. 112, 160–169 (2003).
Blavier, L. & Delaisse, J.M. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J. Cell Sci. 108, 3649–3659 (1995).
Vu, T.H. et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411–422 (1998).
Goto, T., Yamaza, T. & Tanaka, T. Cathepsins in the osteoclast. J. Electron Microsc. (Tokyo) 52, 551–558 (2003).
Stier, S. et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 201, 1781–1791 (2005).
Nilsson, S.K. et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106, 1232–1239 (2005).
Merry, K., Dodds, R., Littlewood, A. & Gowen, M. Expression of osteopontin mRNA by osteoclasts and osteoblasts in modelling adult human bone. J. Cell Sci. 104, 1013–1020 (1993).
Gowen, M. et al. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J. Bone Miner. Res. 14, 1654–1663 (1999).
Chiusaroli, R. et al. Tyrosine phosphatase epsilon is a positive regulator of osteoclast function in vitro and in vivo. Mol. Biol. Cell 15, 234–244 (2004).
Molendijk, W.J., van Oudenaren, A., van Dijk, H., Daha, M.R. & Benner, R. Complement split product C5a mediates the lipopolysaccharide-induced mobilization of CFU-s and haemopoietic progenitor cells, but not the mobilization induced by proteolytic enzymes. Cell Tissue Kinet. 19, 407–417 (1986).
Grassi, F. et al. Human osteoclasts express different CXC chemokines depending on cell culture substrate: molecular and immunocytochemical evidence of high levels of CXCL10 and CXCL12. Histochem. Cell Biol. 120, 391–400 (2003).
Wright, L.M. et al. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts. Bone 36, 840–853 (2005).
Yu, X., Huang, Y., Collin-Osdoby, P. & Osdoby, P. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration. J. Bone Miner. Res. 18, 1404–1418 (2003).
Fujii, K. et al. Elevation of serum hepatocyte growth factor during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Br. J. Haematol. 124, 190–194 (2004).
Grano, M. et al. Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proc. Natl. Acad. Sci. USA 93, 7644–7648 (1996).
Zaidi, M., Inzerillo, A.M., Moonga, B.S., Bevis, P.J. & Huang, C.L. Forty years of calcitonin–where are we now? A tribute to the work of Iain Macintyre, FRS. Bone 30, 655–663 (2002).
Christopherson, K.W., Cooper, S. & Broxmeyer, H.E. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood 101, 4680–4686 (2003).
McQuibban, G.A. et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J. Biol. Chem. 276, 43503–43508 (2001).
Johnell, O. & Hulth, A. Proliferation of osteoclasts in rat bone following bleeding and femoral fractures. Calcif. Tissue Res. 23, 241–244 (1977).
Abu-Amer, Y., Ross, F.P., Edwards, J. & Teitelbaum, S.L. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J. Clin. Invest. 100, 1557–1565 (1997).
Crestani, B. et al. Differential role of neutrophils and alveolar macrophages in hepatocyte growth factor production in pulmonary fibrosis. Lab. Invest. 82, 1015–1022 (2002).
Armbrust, T., Batusic, D., Xia, L. & Ramadori, G. Early gene expression of hepatocyte growth factor in mononuclear phagocytes of rat liver after administration of carbon tetrachloride. Liver 22, 486–494 (2002).
Matsuda-Hashii, Y. et al. Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1 alpha, and stem cell factor. Exp. Hematol. 32, 955–961 (2004).
Hattori, K. et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97, 3354–3360 (2001).
Shen, H. et al. CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells. J. Immunol. 166, 5027–5033 (2001).
Grassi, F. et al. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. J. Cell. Physiol. 199, 244–251 (2004).
Janowska-Wieczorek, A., Matsuzaki, A. & Marquez, L.A. The hematopoietic microenvironment: matrix metalloproteinases in the hematopoietic microenvironment. Hematology 4, 515–527 (2000).
Dar, A. et al. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat. Immunol. 6, 1038–1046 (2005).
Lee, S.K., Gardner, A.E., Kalinowski, J.F., Jastrzebski, S.L. & Lorenzo, J.A. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production. Bone 38, 678–685 (2005).
Jones, D.H. et al. Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440, 692–696 (2006).
Okada, Y. et al. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab. Invest. 72, 311–322 (1995).
Perez-Amodio, S., Beertsen, W. & Everts, V. (Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts. J. Bone Miner. Res. 19, 1722–1731 (2004).
Semerad, C.L. et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106, 3020–3027 (2005).
Katayama, Y. et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124, 407–421 (2006).
Adams, G.B. et al. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 439, 599–603 (2005).
Vaaraniemi, J. et al. Intracellular machinery for matrix degradation in bone-resorbing osteoclasts. J. Bone Miner. Res. 19, 1432–1440 (2004).
Kiviranta, R. et al. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio. Bone 36, 159–172 (2005).